Publication | Closed Access

Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants

Tissue EngineeringSclerostinAngiogenesisBone Morphogenic ProteinMedicineHeparan Sulfate-binding SiteVascular BiologySitu BindingPharmacologyCell BiologyOsteoporosisBone ExplantsExtracellular Matrix